Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial

Clinical article

Restricted access

Object

The study aimed to verify the safety and feasibility of applying acidic fibroblast growth factor (aFGF) with fibrin glue in combination with surgical neurolysis for nonacute spinal cord injury.

Methods

This open-label, prospective, uncontrolled human clinical trial recruited 60 patients with spinal cord injuries (30 cervical and 30 thoracolumbar). The mean patient age was 36.5 ± 15.33 (mean ± SD) years, and the male/female ratio was 3:1. The mean time from injury to treatment was 25.7 ± 26.58 months, and the cause of injury included motor vehicle accident (26 patients [43.3%]), fall from a height (17 patients [28.3%]), sports (4 patients [6.7%]), and other (13 patients [21.7%]). Application of aFGF with fibrin glue and duraplasty was performed via laminectomy, and an adjuvant booster of combined aFGF and fibrin glue (2 ml) was given at 3 and 6 months postsurgery via lumbar puncture. Outcome measurements included the American Spinal Injury Association (ASIA) motor scores, sensory scores, impairment scales, and neurological levels. Examination of functional independence measures, visual analog scale, MR imaging, electrophysiological and urodynamic studies, hematology and biochemistry tests, tumor markers, and serum inflammatory cytokines were all conducted. All adverse events were monitored and reported. Exclusions were based on refusal, unrelated adverse events, or failure to participate in the planned rehabilitation.

Results

Forty-nine patients (26 with cervical and 23 with thoracolumbar injuries) completed the 24-month trial. Compared with preoperative conditions, the 24-month postoperative ASIA motor scores improved significantly in the cervical group (from 27.6 ± 15.55 to 37.0 ± 19.93, p < 0.001) and thoracolumbar group (from 56.8 ± 9.21 to 60.7 ± 10.10, p < 0.001). The ASIA sensory scores also demonstrated significant improvement in light touch and pinprick in both groups: from 55.8 ± 24.89 to 59.8 ± 26.47 (p = 0.049) and 56.3 ± 23.36 to 62.3 ± 24.87 (p = 0.003), respectively, in the cervical group and from 75.7 ± 15.65 to 79.2 ± 15.81 (p < 0.001) and 78.2 ± 14.72 to 82.7 ± 16.60 (p < 0.001), respectively, in the thoracolumbar group. At 24-month follow-up, the ASIA impairment scale improved significantly in both groups (30% cervical [p = 0.011] and 30% thoracolumbar [p = 0.003]). There was also significant improvement in neurological level in the cervical (from 5.17 ± 1.60 to 6.27 ± 3.27, p = 0.022) and thoracolumbar (from 18.03 ± 4.19 to 18.67 ± 3.96, p = 0.001) groups. The average sum of motor items in functional independence measure also had significant improvement in both groups (p < 0.05). The walking/wheelchair locomotion subscale showed increased percentages of patients who were ambulatory (from 3.4% to 13.8% and from 17.9% to 35.7% in the cervical and thoracolumbar groups, respectively). There were no related adverse events.

Conclusions

The use of aFGF for spinal cord injury was safe and feasible in the present trial. There were significant improvements in ASIA motor and sensory scale scores, ASIA impairment scales, neurological levels, and functional independence measure at 24 months after treatment. Further large-scale, randomized, and controlled investigations are warranted to evaluate the efficacy and long-term results.

Abbreviations used in this paper: aFGF = acidic fibroblast growth factor; ASIA = American Spinal Injury Association; SCI = spinal cord injury; VAS = visual analog scale.
Article Information

Contributor Notes

Address correspondence to: Henrich Cheng, M.D., Ph.D., Center for Neural Regeneration, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, 2F, No. 322, Shih-Pai Road, Sec. 2, Peitou, Taipei 11217, Taiwan, Republic of China. email: hc_cheng@vghtpe.gov.tw.Please include this information when citing this paper: published online June 10, 2011; DOI: 10.3171/2011.4.SPINE10404.
Headings
References
  • 1

    Bunge MB: Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 31:2622692008

  • 2

    Cheng HAlmström SGiménez-Llort LChang ROve Ogren SHoffer B: Gait analysis of adult paraplegic rats after spinal cord repair. Exp Neurol 148:5445571997

    • Search Google Scholar
    • Export Citation
  • 3

    Cheng HCao YOlson L: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273:5105131996

    • Search Google Scholar
    • Export Citation
  • 4

    Cheng HLiao KKLiao SFChuang TYShih YH: Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976) 29:E284E2882004

    • Search Google Scholar
    • Export Citation
  • 5

    Chuang TYHuang MCChen KCChang YCYen YSLee LS: Forelimb muscle activity following nerve graft repair of ventral roots in the rat cervical spinal cord. Life Sci 71:4874962002

    • Search Google Scholar
    • Export Citation
  • 6

    Eftekharpour EKarimi-Abdolrezaee SFehlings MG: Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 24:3–4E192008

    • Search Google Scholar
    • Export Citation
  • 7

    Guest JDHesse DSchnell LSchwab MEBunge MBBunge RP: Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J Neurosci Res 50:8889051997

    • Search Google Scholar
    • Export Citation
  • 8

    Hashimoto MSagara YLangford DEverall IPMallory MEverson A: Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection J Biol Chem 277:32985329912002

    • Search Google Scholar
    • Export Citation
  • 9

    Hsu SPShih YHHuang MCChuang TYHuang WCWu HM: Repair of multiple cervical root avulsion with sural nerve graft. Injury 35:8969072004

    • Search Google Scholar
    • Export Citation
  • 10

    Huang MCChen KCChuang TYChang WCLee LSHuang WC: Cervical root repair in adult rats after transection: recovery of forelimb motor function. Exp Neurol 180:1011092003

    • Search Google Scholar
    • Export Citation
  • 11

    Huang MCLo MJLin YLChang SEHuang WCKuo WC: Functional recovery after the repair of transected cervical roots in the chronic stage of injury. J Neurotrauma 26:179518042009

    • Search Google Scholar
    • Export Citation
  • 12

    Huang WCKuo WCCherng JHHsu SHChen PRHuang SH: Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 349:9639682006

    • Search Google Scholar
    • Export Citation
  • 13

    Huang WCKuo WCHsu SHCheng CHLiu JCCheng H: Gait analysis of spinal cord injured rats after delivery of chondroitinase ABC and adult olfactory mucosa progenitor cell transplantation. Neurosci Lett 472:79842010

    • Search Google Scholar
    • Export Citation
  • 14

    Imamura TOka STanahashi TOkita Y: Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp Cell Res 215:3633721994

    • Search Google Scholar
    • Export Citation
  • 15

    Kadoya KTsukada SLu PCoppola GGeschwind DFilbin MT: Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 64:1651722009

    • Search Google Scholar
    • Export Citation
  • 16

    Kirshblum SMillis SMcKinley WTulsky D: Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil 85:181118172004

    • Search Google Scholar
    • Export Citation
  • 17

    Lee YSHsiao ILin VW: Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J Neurotrauma 19:120312162002

    • Search Google Scholar
    • Export Citation
  • 18

    Lee YSLin CYCaiozzo VJRobertson RTYu JLin VW: Repair of spinal cord transection and its effects on muscle mass and myosin heavy chain isoform phenotype. J Appl Physiol 103:180818142007

    • Search Google Scholar
    • Export Citation
  • 19

    Lee YSLin CYRobertson RTYu JDeng XHsiao I: Re-growth of catecholaminergic fibers and protection of cholinergic spinal cord neurons in spinal repaired rats. Eur J Neurosci 23:6937022006

    • Search Google Scholar
    • Export Citation
  • 20

    Lin PHCheng HHuang WCChuang TY: Spinal cord implantation with acidic fibroblast growth factor as a treatment for root avulsion in obstetric brachial plexus palsy. J Chin Med Assoc 68:3923962005

    • Search Google Scholar
    • Export Citation
  • 21

    Lin PHChuang TYLiao KKCheng HShih YS: Functional recovery of chronic complete idiopathic transverse myelitis after administration of neurotrophic factors. Spinal Cord 44:2542572006

    • Search Google Scholar
    • Export Citation
  • 22

    Mackay-Sim AFéron FCochrane JBassingthwaighte LBayliss CDavies W: Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131:237623862008

    • Search Google Scholar
    • Export Citation
  • 23

    Małecki JWiedłocha AWesche JOlsnes S: Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1. EMBO J 21:448044902002

    • Search Google Scholar
    • Export Citation
  • 24

    Park KKLiu KHu YSmith PDWang CCai B: Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:9639662008

    • Search Google Scholar
    • Export Citation
  • 25

    Rihn JAAnderson DTSasso RCZdeblick TALenke LGHarris MB: Emergency evaluation, imaging, and classification of thoracolumbar injuries. Instr Course Lect 58:6196282009

    • Search Google Scholar
    • Export Citation
  • 26

    Tator CH: Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery 59:9579872006

    • Search Google Scholar
    • Export Citation
  • 27

    Tsai ECKrassioukov AVTator CH: Corticospinal regeneration into lumbar grey matter correlates with locomotor recovery after complete spinal cord transection and repair with peripheral nerve grafts, fibroblast growth factor 1, fibrin glue, and spinal fusion. J Neuropathol Exp Neurol 64:2302442005

    • Search Google Scholar
    • Export Citation
  • 28

    Tsai MCShen LFKuo HSCheng HChak KF: Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach. Mol Cell Proteomics 7:166816872008

    • Search Google Scholar
    • Export Citation
  • 29

    Tsai PYCheng HHuang WCHuang MCChiu FYChang YC: Outcomes of common peroneal nerve lesions after surgical repair with acidic fibroblast growth factor. J Trauma 66:137913842009

    • Search Google Scholar
    • Export Citation
  • 30

    Wu JCHuang WCHuang MCTsai YAChen YCShih YH: A novel strategy for repairing preganglionic cervical root avulsion in brachial plexus injury by sural nerve grafting. Clinical article. J Neurosurg 110:7757852009

    • Search Google Scholar
    • Export Citation
  • 31

    Wu JCHuang WCTsai YAChen YCCheng H: Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study. J Neurosurg Spine 8:2082142008

    • Search Google Scholar
    • Export Citation
  • 32

    Yang LJLorenzini IVajn KMountney ASchramm LPSchnaar RL: Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A 103:11057110622006

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 301 256 22
Full Text Views 120 80 1
PDF Downloads 179 52 1
EPUB Downloads 0 0 0
PubMed
Google Scholar